
|Articles|May 15, 2003
ICL effective treatment for moderate, high hyperopia
Author(s)Julia Talsma
San Francisco-At 1-year follow-up, the majority of patients who received the hyperopic Implantable Contact Lens (ICL, STAAR Surgical, Monrovia, CA) for correction of moderate to high hyperopia were satisfied with an uncorrected visual acuity (UCVA) of at least 20/40 or better, noted Paul J. Dougherty, MD, who spoke during the American Society of Cataract and Refractive Surgery Annual Meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Reasoning prompts sharpen multimodal AI on bilingual ophthalmology exam questions
3
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
4
Phase 3 NORTHSTAR trial launches for gildeuretinol in stargardt disease
5





















